Therapy Areas
18 March 2024 - Medical equipment manufacturer Neupulse announced on Monday that it has secured USD3.2m seed funding led by Eos Advisory and US investors to advance world's first wearable device aimed at tackling Tourettes Syndrome (TS) and othe...
18 March 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) on Monday revealed significant overall survival (OS) data from RUBY phase III trial, indicating the potential of Jemperli (dostarlimab) in combination therapies for primary advanced or...
18 March 2024 - ImmVira, a biotechnology company focused on developing and synthesising a biological vector delivery platform, announced on Friday that it has received Fast Track designation from the US Food and Drug Administration (FDA) for oncolyti...
18 March 2024 - Everest Medicines (HKEX: 1952.HK) ('Everest'), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialisation of innovative medicines and vaccines, announced on Sunday that it has name...
15 March 2024 - Precisio Biotix Therapeutics ('Precisio'), a clinical-stage biotech company, announced on Thursday that it has signed a contract with Mayo Clinic.The partnership covers co-development of novel precision antibacterials aimed ...
15 March 2024 - Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company, announced on Thursday that it has received a multi-year USD14m grant from National Institute on Drug Abuse (NIDA).The funds are to be used to develop GM-3009, the compa...
15 March 2024 - D3 Bio, an emerging global biotechnology company, announced on Thursday that it has named Antoine Yver, MD, MSc as an independent board member.Dr Yver has served in the global pharmaceutical industry for 34 years, with a focus on canc...